Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

NCT00283413 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00283413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2002
Completion date
March 31, 2009
Enrollment
514 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic ischemic saphenous vein graft disease